An open‐label pilot study on an adsorbent mousse containing adelmidrol in client‐owned cats with feline atopic skin syndrome and associated seborrhoea
Veterinary Dermatology · 2025
DOI: 10.1111/vde.13346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2025. Verfasst von Chiara Noli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Servizi Dermatologici Veterinari, Peveragno, Italy. Hauptthemen laut MEDLINE: Cat Diseases, Dermatitis, Atopic, Dermatitis, Seborrheic. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Besides pruritus and skin lesions, cats with feline atopic skin syndrome (FASS) may have seborrhoea. Hypothesis/Objectives The aim of this pilot study was to investigate whether an adsorbent mousse containing tapioca starch, adelmidrol and a nonpharmacological antimicrobial complex could decrease FASS‐associated seborrhoea in cats. Animals Seven client‐owned cats with FASS were included based on the presence of seborrhoea and pruritus (>4 cm on the validated feline pruritus Visual Analog Scale [VAScat]), regardless of the concomitant administration of antiallergic drugs, provided that they were used for ≥1 month before study entry and maintained unchanged. Materials and Methods Cats were evaluated weekly by owners and every other week by veterinary surgeons for 2 (optionally 4) weeks using a four‐item skin seborrhoeic index (SSI). The VAScat and the scoring feline allergic dermatitis (SCORFAD) index also were used to assess pruritus and skin lesion severity, respectively. The Wilcoxon signed‐rank test was used for pre‐ versus post‐treatment comparisons.
Results
At the end of Week 2, the mean score value for SSI was significantly decreased ( p = 0.016). At the same time point, the mean severity of pruritus and the mean SCORFAD index value had also decreased ( p = 0.016). Moreover, 86% of the investigators were ‘satisfied’ or ‘very satisfied’ with the tested mousse. Four cats continued the study up to Week 4 and showed a further, albeit nonsignificant, decrease in all evaluated scores. Conclusions and Clinical Relevance These preliminary findings have promising implications for clinical practice in cats with FASS‐associated seborrhoea and are worth further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servizi Dermatologici Veterinari, Peveragno, Italy.
- Science Information and Documentation Centre, Innovet Italia Srl, Saccolongo, Italy.
- Innovative Statistical Research SRL, Padova, Italy.
ORCID-Profile: Chiara Noli
Zitieren
APA
Noli, C., Della Valle, M. F., Morelli, G., Schievano, C., & Skinalia Clinical Research Group (2025). An open‐label pilot study on an adsorbent mousse containing adelmidrol in client‐owned cats with feline atopic skin syndrome and associated seborrhoea. Veterinary Dermatology. https://doi.org/10.1111/vde.13346
Vancouver
Noli C, Della Valle MF, Morelli G, Schievano C, Skinalia Clinical Research Group. An open‐label pilot study on an adsorbent mousse containing adelmidrol in client‐owned cats with feline atopic skin syndrome and associated seborrhoea. Veterinary Dermatology. 2025. doi:10.1111/vde.13346
BibTeX
@article{Noli2025,
author = {Noli, Chiara and Della Valle, Maria Federica and Morelli, Giada and Schievano, Carlo and Skinalia Clinical Research Group, Skinalia Clinical Research Group},
title = {An open‐label pilot study on an adsorbent mousse containing adelmidrol in client‐owned cats with feline atopic skin syndrome and associated seborrhoea},
journal = {Veterinary Dermatology},
year = {2025},
doi = {10.1111/vde.13346}
}
EUVIMED